{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T17:53:04Z","timestamp":1725645184056},"publisher-location":"Berlin, Heidelberg","reference-count":60,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642841408"},{"type":"electronic","value":"9783642841385"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1991]]},"DOI":"10.1007\/978-3-642-84138-5_40","type":"book-chapter","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T04:37:47Z","timestamp":1324528667000},"page":"337-346","source":"Crossref","is-referenced-by-count":0,"title":["Prevention of Infections in Granulocytopenic Patients by Fluorinated Quinolones"],"prefix":"10.1007","author":[{"given":"M.","family":"Rozenberg-Arska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. W.","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"40_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF02001575","volume":"2","author":"A Bauernfeind","year":"1983","unstructured":"Bauernfeind A, Petermuller C (1983) In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. Eur J Clin Microbiol 2: 111\u2013115","journal-title":"Eur J Clin Microbiol"},{"key":"40_CR2","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/S0140-6736(80)91436-1","volume":"1","author":"HA Blacklock","year":"1980","unstructured":"Blacklock HA, Hill RS, Clarke AG, Pillai MV, Matthews JRD, Wade JF (1980) Use of modified subcutaneous right-atrial catheter for venous access in leukemic patients. Lancet 1: 993\u2013994","journal-title":"Lancet"},{"key":"40_CR3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","volume":"64","author":"GP Bodey","year":"1966","unstructured":"Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64: 328\u2013340","journal-title":"Ann Intern Med"},{"key":"40_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/1097-0142(197908)44:2<431::AID-CNCR2820440209>3.0.CO;2-4","volume":"44","author":"GP Bodey","year":"1979","unstructured":"Bodey GP, McCredie KB, Keating MJ, Freireich EJ (1979) Treatment of acute leukemia in protected environment units. Cancer 44: 431\u2013436","journal-title":"Cancer"},{"key":"40_CR5","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/1097-0142(197804)41:4<1610::AID-CNCR2820410452>3.0.CO;2-B","volume":"41","author":"GP Bodey","year":"1978","unstructured":"Bodey GP, Rodriguez V, Chang H-Y, Narboni G (1978) Fever and infections in leukemic patients. A study of 494 consecutive patients. Cancer 41: 1610\u20131622","journal-title":"Cancer"},{"key":"40_CR6","first-page":"89","volume-title":"Protective environment for marrow transplant recipients","author":"CD Buckner","year":"1978","unstructured":"Buckner CD, Clift RA, Sanders JE, Meyers JD, Counts GW, Farewell VT, Thomas ED, Seattle Marrow Transplant team (1978) Protective environment for marrow transplant recipients. A prospective study. Ann Intern Med 89: 893\u2013901"},{"key":"40_CR7","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/S0140-6736(83)90799-7","volume":"2","author":"J Cohen","year":"1983","unstructured":"Cohen J, Donnelly JP, Worsley AM, Catovsky D, Goldman JM, Galton DAG (1983) Septicemia caused by viridans streptococci in neutropenic patients with leukemia. Lancet 2: 1452\u20131454","journal-title":"Lancet"},{"key":"40_CR8","first-page":"24","volume-title":"The pharmacokinetics and tissue penetration of ciprofloxacin","author":"B Crump","year":"1983","unstructured":"Crump B, Wise R, and Dent J (1983) The pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrob Agents. Chemother 24: 784\u2013786"},{"key":"40_CR9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-95-5-555","volume":"95","author":"AW Dekker","year":"1981","unstructured":"Dekker AW, Rozenberg-Arska M, Sixma JJ, Verhoef J (1981) Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukemia. Ann Intern Med 95: 555\u2013559","journal-title":"Ann Intern Med"},{"key":"40_CR10","first-page":"30","volume-title":"Acute Leukemias. Springer, Berlin Heidelberg New York, pp 333-335 (Haematology and blood transfusion vol","author":"AW Dekker","year":"1987","unstructured":"Dekker AW, Punt K, Verdonck LF (1987a) The use of amsacrine plus intermediate-dose cytosine arabinoside in relapsed and refractory acute nonlymphocytic leukemia. In: B\u00fcchner T, Schellong G, Hiddemann W, Urbanitz D, Ritter J (eds) Acute Leukemias. Springer, Berlin Heidelberg New York, pp 333\u2013335 (Haematology and blood transfusion vol 30 )"},{"key":"40_CR11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-106-1-7","volume":"106","author":"AW Dekker","year":"1987","unstructured":"Dekker AW, Rozenberg-Arska M, Verhoef J (1987b) Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim\/sulfamethoxazole and colistin. Ann Intern Med 106: 7\u201312","journal-title":"Ann Intern Med"},{"key":"40_CR12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.7326\/0003-4819-95-6-783_3","volume":"95","author":"CA Jongh","year":"1981","unstructured":"de Jongh CA, Schimpff SC, Wiernik PH (1981) Antibiotic prophylaxis in acute leukemia. Ann Intern Med 95: 783\u2013784","journal-title":"Ann Intern Med"},{"key":"40_CR13","first-page":"107","volume":"5","author":"M Dietrich","year":"1977","unstructured":"Dietrich M, Gaus W, Vossen J, van der Waaij D, Wendt F (1977) Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in leukemia patients. I. Clinical results. Infection 5: 107\u2013114","journal-title":"I. Clinical results. Infection"},{"key":"40_CR14","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/0002-9343(83)90785-4","volume":"74","author":"RJ Gualtieri","year":"1983","unstructured":"Gualtieri RJ, Donovitz GR, Kaiser DL, Hess CE, Saride MA (1983) Double blind randomized study of prophylactic trimethoprim-sulfamethoxazole in granulocytopenic patients with haematologic malignancies. Am J Med 74: 934\u201340","journal-title":"Am J Med"},{"key":"40_CR15","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/bmj.1.6064.798-a","volume":"1","author":"HFL Guiot","year":"1977","unstructured":"Guiot HFL, van Furth R (1977) Partial decontamination. Br Med J 1: 800\u2013802","journal-title":"Br Med J"},{"key":"40_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/infdis\/147.4.615","volume":"47","author":"HFL Guiot","year":"1983","unstructured":"Guiot HFL, van den Broeke JWM, van der Meer JWM, van Furth R (1983) Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind placebo controlled study. J Infect Dis 47: 615\u2013623","journal-title":"J Infect Dis"},{"key":"40_CR17","first-page":"64","volume-title":"Granulocytopenia in hospitalized patients. I","author":"MJ Gurwith","year":"1978","unstructured":"Gurwith MJ, Brunton JL, Lank BA, Ronald AR, Harding GKM (1978) Granulocytopenia in hospitalized patients. I. Prognostic factors and etiology of fever. Am J Med 64: 121\u2013126"},{"key":"40_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0002-9343(79)90539-4","volume":"66","author":"MJ Gurwith","year":"1979","unstructured":"Gurwith MJ, Brunton JL, Lank BA, Harding GLM, Ronald AR (1979) A prospective controlled investigation of prophylactic trimethoprim\/sulfamethoxazole in hospitalized granulocytopenic patients. Am J Med 66: 248\u2013256","journal-title":"Am J Med"},{"key":"40_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0140-6736(84)90440-9","volume":"1","author":"J Henslee","year":"1984","unstructured":"Henslee J, Bostrom B, Weidsdorf D, Ramsay N, McGlave P, Kersey J (1984) Streptococcal sepsis in bone marrow transplant patients. Lancet 1: 393","journal-title":"Lancet"},{"key":"40_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1056\/NEJM198201073060111","volume":"306","author":"GA Jacoby","year":"1982","unstructured":"Jacoby GA (1982) Perils of prophylaxis. N Engl J Med 306: 43\u201344","journal-title":"N Engl J Med"},{"key":"40_CR21","first-page":"106","volume-title":"Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia","author":"JE Karp","year":"1987","unstructured":"Karp JE, Merz WG, Hendricksen C, Laughon B, Redden T, Bamberger BJ, Bartlett JG, Sarai L, Burke PJ (1987) Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 106: 1\u20137"},{"key":"40_CR22","first-page":"74","volume-title":"Trimethoprimsulfamethoxazole prophylaxis in neutropenic patients","author":"CA Kaufman","year":"1983","unstructured":"Kaufman CA, Liepman MK, Bergman AG, Mioduszewski J (1983) Trimethoprimsulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora. Am J Med 74: 599\u2013607"},{"key":"40_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/BF01647222","volume":"15","author":"W Kern","year":"1987","unstructured":"Kern W, Kurrle E, Vanek E (1987a) Ofloxacin for prevention of bacterial infections in granulocytopenic patients. Infection 15: 427\u2013432","journal-title":"Infection"},{"key":"40_CR24","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/BF01743253","volume":"65","author":"W Kern","year":"1987","unstructured":"Kern W, Kurrle E, Vanek E (1987b) High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemia. Klin Wochenschr 65: 773\u2013780","journal-title":"Klin Wochenschr"},{"key":"40_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/BF01644268","volume":"14","author":"E Kurrle","year":"1986","unstructured":"Kurrle E, Dekker AW, Gaus W, Haralambie E, Krieger D, Rozenberg-Arska M, De Vries-Hospersd HG, van der Waaij D, Wendt F (1986) Prevention of infection in acute leukaemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis. Infection 14: 226\u2013232","journal-title":"Infection"},{"key":"40_CR26","first-page":"288","volume-title":"Protected environments and prophylactic antibiotics","author":"AS Levine","year":"1973","unstructured":"Levine AS, Siegel SE, Schreiber AD, Hauser J, Preisler H, Goldstein IM, Seidler F, Simon R, Perry S, Bennett JE, Henderson ES (1973) Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med 288: 477\u2013483"},{"key":"40_CR27","first-page":"363","volume":"63","author":"D Lohner","year":"1979","unstructured":"Lohner D, Debusscher L, Prevost JM, Klastersky J (1979) Comparative randomized study of protected environment plus oral antibiotics versus oral antibiotics alone in neutropenic patients. Cancer Treat Rep 63: 363\u2013368","journal-title":"Cancer Treat Rep"},{"key":"40_CR28","first-page":"142","volume-title":"Bacteremias and fungemias in oncologic patients with central venous catheters","author":"JN Lowder","year":"1982","unstructured":"Lowder JN, Lazarus HM, Herzig RH (1982) Bacteremias and fungemias in oncologic patients with central venous catheters. Changing spectrum of infection. Arch Intern Med 142: 1456\u20131459"},{"key":"40_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/BF01644312","volume":"16","author":"G Maschmeyer","year":"1988","unstructured":"Maschmeyer G, Haralambie E, Gaus W, Kern W, Dekker AW, De Vries-Hospers HG, Sizoo W, K\u00f6nig W, Gutzler F, Daenen S (1988) Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia. Infection 16: 98\u2013104","journal-title":"Infection"},{"key":"40_CR30","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1600-0609.1988.tb00824.x","volume":"40","author":"WG Peters","year":"1988","unstructured":"Peters WG, Willemze R, Colly LP (1988) Results of induction and consolidation treatment with intermediate and high-dose cytosine arabinoside and m-AMSA of patients with poor-risk acute myelogenous leukemia. Eur J Hematol 40: 198\u2013204","journal-title":"Eur J Hematol"},{"key":"40_CR31","first-page":"223","volume":"67","author":"PA Pizzo","year":"1983","unstructured":"Pizzo PA, Schimpff SC (1983) Strategies for the prevention of infection in the myelosuppressed or immunosuppressed cancer patient. Cancer Treat Rep 67: 223\u201334","journal-title":"Cancer Treat Rep"},{"key":"40_CR32","first-page":"102","volume-title":"Oral antibiotic prophylaxis in patients with cancer","author":"PA Pizzo","year":"1983","unstructured":"Pizzo PA, Robichaud K, Edwards B (1983) Oral antibiotic prophylaxis in patients with cancer. A double blind randomized placebo controlled trial. J Pediatr 102: 125\u2013133"},{"key":"40_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/00005792-197805000-00005","volume":"57","author":"V Rodriguez","year":"1978","unstructured":"Rodriguez V, Bodey GP, Freireich EJ, McCredie KB, Gutterman JU, Keating MJ, Smith TL, Gehan EA (1978) Randomized trial of protected environment\u2014prophylactic antibiotics in 145 adults with acute leukemia. Medicine 57: 253\u2013266","journal-title":"Medicine"},{"key":"40_CR34","first-page":"471","volume-title":"Antimicrobial agents annual","author":"M Rozenberg-Arska","year":"1978","unstructured":"Rozenberg-Arska M, Dekker AW (1978) Prevention of bacterial and fungal infection in granulocytopenic patients. In: Peterson PK, Verhoef J (eds) Antimicrobial agents annual 2. Elsevier, Amsterdam, pp 471\u2013481"},{"key":"40_CR35","first-page":"11","volume-title":"Colistin and trimethoprim sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukemia","author":"M Rozenberg-Arska","year":"1983","unstructured":"Rozenberg-Arska M, Dekker AW, Verhoef J (1983) Colistin and trimethoprim sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukemia. Decrease in the emergence of resistant bacteria. Infection 11: 167\u2013169"},{"key":"40_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/infdis\/152.1.104","volume":"152","author":"M Rozenberg-Arska","year":"1985","unstructured":"Rozenberg-Arska M, Dekker AW, Verhoef J (1985) Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora. J Infect Dis 152: 104\u2013107","journal-title":"J Infect Dis"},{"key":"40_CR37","first-page":"17","volume-title":"Prevention of gram-positive bacteremias by a short course of roxithromycin (RU) in granulocytopenic patients receiving ciprofloxacin","author":"M Rozenberg-Arska","year":"1989","unstructured":"Rozenberg-Arska M, Dekker AW, Verdonck LF, Verhoef J (1989) Prevention of gram-positive bacteremias by a short course of roxithromycin (RU) in granulocytopenic patients receiving ciprofloxacin ( CF) prophylactically. Infection 17: 240\u2013244"},{"key":"40_CR38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.7326\/0003-4819-93-2-358","volume":"93","author":"SC Schimpff","year":"1980","unstructured":"Schimpff SC (1980) Infection prevention during profound granulocytopenia. New approaches to alimentary canal microbial suppression. Ann Intern Med 93: 358\u2013361","journal-title":"Ann Intern Med"},{"key":"40_CR39","first-page":"77","volume-title":"Origin of infection in acute nonlymphocytic leukemia","author":"SC Schimpff","year":"1972","unstructured":"Schimpff SC, Young VM, Greene WH, Vermeulen GD, Moody MR, Wiernik PH (1972) Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Intern Med 77: 707\u2013714"},{"key":"40_CR40","first-page":"82","volume-title":"Infection prevention in acute non-lymphocytic leukemia","author":"SC Schimpff","year":"1975","unstructured":"Schimpff SC, Greene WH, Young VM, Fortner CL, Jepsen L, Cusack N, Block JB, Wiernik PH (1975) Infection prevention in acute non-lymphocytic leukemia. Laminar air flow room reverse isolation with oral, non-absorbable antibiotic prophylaxis. Ann Intern Med 82: 351\u2013358"},{"key":"40_CR41","first-page":"29","volume":"7","author":"KP Shannon","year":"1985","unstructured":"Shannon KP, Phillips I (1985) The antimicrobial spectrum of the quinolones. Res Clin Forum 7: 29\u201336","journal-title":"Res Clin Forum"},{"key":"40_CR42","first-page":"859","volume":"16","author":"DT Sleijfer","year":"1980","unstructured":"Sleijfer DTh, Mulder NH, de Vries-Hospers HG, Fidler V, Nieweg HO, Van der Waaij D, Van Saene HKF (1980) Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer 16: 859\u2013869","journal-title":"Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer"},{"key":"40_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0140-6736(82)92553-3","volume":"1","author":"JD Starke","year":"1982","unstructured":"Starke JD, Catovsky D, Johnson SA, Donnelly P, Darrel J, Goldman JM, Galton DAG (1982) Cotrimoxazole alone for prevention of bacterial infection in patients with acute leukemia. Lancet 1: 5\u20136","journal-title":"Lancet"},{"issue":"1","key":"40_CR44","first-page":"409A","volume":"72","author":"M Steiner","year":"1548","unstructured":"Steiner M, Villablanca J, Kersey J, Ramsay N, Ferrier M, Haake R, Weisdorf D (1988) a-streptococcal shock in bone marrow transplantation patients (abstract no. 1548 ). Blood 72 (suppl 1): 409A","journal-title":"Blood"},{"key":"40_CR45","first-page":"271","volume-title":"New criteria for antimicrobial therapy: maintenance of digestive tract colonization resistance. Excerpta","author":"D Waaij","year":"1979","unstructured":"van der Waaij D (1979) Colonization resistance of the digestive tract as a major lead in the selection of antibiotics for therapy. In: Van der Waaij D, Verhoef J (eds) New criteria for antimicrobial therapy: maintenance of digestive tract colonization resistance. Excerpta. Medica, Amsterdam, pp 271\u2013282"},{"key":"40_CR46","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1017\/S0022172400023615","volume":"72","author":"D Waaij","year":"1974","unstructured":"van der Waaij D, Berghuis JM (1974) Determination of the colonization resistance of the digestive tract of individual mice. J Hyg (Camb) 72: 379\u2013387","journal-title":"J Hyg (Camb)"},{"key":"40_CR47","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1017\/S002217240002341X","volume":"72","author":"D Waaij","year":"1974","unstructured":"van der Waaij D, Berghuis-de Vries JM (1974) Selective elimination of Enterobacteriaceae species from the digestive tract in mice and monkeys. J Hyg (Camb) 72: 205\u2013211","journal-title":"J Hyg (Camb)"},{"key":"40_CR48","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1017\/S0022172400021653","volume":"69","author":"D Waaij","year":"1971","unstructured":"van der Waaij D, Berghuis-de Vries JM, Lekkerkerk-van der Wees JEC (1971) Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg (Camb) 69: 405\u2013411","journal-title":"J Hyg (Camb)"},{"key":"40_CR49","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1017\/S0022172400022464","volume":"70","author":"D Waaij","year":"1972","unstructured":"van der Waaij D, Berghuis JM, Lekkerkerk JEC (1972) Colonization resistance of the digestive tract of mice during systemic antibiotic treatment. J Hyg (Camb) 70: 605\u2013610","journal-title":"J Hyg (Camb)"},{"key":"40_CR50","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1056\/NEJM198104303041801","volume":"304","author":"JC Wade","year":"1981","unstructured":"Wade JC, Schimpff SC, Hargadon MT, Fortner CL, Young VM, Wiernik PH (1981) A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. N Engl J Med 304: 1057\u20131062","journal-title":"N Engl J Med"},{"key":"40_CR51","first-page":"624","volume":"147","author":"JC Wade","year":"1983","unstructured":"Wade JC, de Jongh CA, Newman KA, Crowley J, Wiernik PH, Schimpff SC (1983) Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid. J Infect Dis 147: 624\u2013634","journal-title":"Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid. J Infect Dis"},{"key":"40_CR52","doi-asserted-by":"crossref","unstructured":"Watson JG, Powles RL, Lawson DN, Morgenstern GR, Jameson B, McElwain TJ, Judson J, Lumley H, Kay HEM (1982) Contrimoxazole versus nonabsorbable antibiotics in acute leukemia. Lancet I: 6\u20139","DOI":"10.1016\/S0140-6736(82)92554-5"},{"key":"40_CR53","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/IAI.55.11.2689-2694.1987","volume":"55","author":"CL Wells","year":"1987","unstructured":"Wells CL, Maddaus MA, Reynolds CM, Jechorek RP, Simmons RL (1987a) Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria. Infect Immun 55: 2689\u20132694","journal-title":"Infect Immun"},{"key":"40_CR54","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1128\/IAI.55.11.2834-2837.1987","volume":"55","author":"CL Wells","year":"1987","unstructured":"Wells CL, Maddaus MA, Jechorek RP, Simmons RL (1987b) Ability of intestinal Escherichia coli to survive within mesenteric lymph nodes. Infect Immun 55: 2834\u20132837","journal-title":"Infect Immun"},{"key":"40_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1056\/NEJM198201073060105","volume":"306","author":"JM Wilson","year":"1982","unstructured":"Wilson JM, Guiney DG (1982) Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia. N Engl J Med 306: 16\u201320","journal-title":"N Engl J Med"},{"key":"40_CR56","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/0002-9343(86)90633-9","volume":"80","author":"DJ Winston","year":"1986","unstructured":"Winston DJ, Ho WG, Nakao SL, Gale RP, Champlin RE (1986) Norfloxacin versus vancomycin\/polymyxin for prevention of infections in granulocytopenic patients. Am J Med 80: 884\u2013890","journal-title":"Am J Med"},{"key":"40_CR57","first-page":"63","volume":"7","author":"R Wise","year":"1985","unstructured":"Wise R, Lockley MR, Crump B, Adhami ZN (1985) The pharmacokinetics and tissue penetration of orally administered enoxacin, norfloxacin and ciprofloxacin. Res Clin Forum 7: 63\u201368","journal-title":"Res Clin Forum"},{"key":"40_CR58","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1002\/1097-0142(197312)32:6<1490::AID-CNCR2820320628>3.0.CO;2-6","volume":"32","author":"JW Yates","year":"1973","unstructured":"Yates JW, Holland JF (1973) A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients. Cancer 32: 1490\u20131498","journal-title":"Cancer"},{"key":"40_CR59","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/infdis\/147.4.611","volume":"147","author":"LS Young","year":"1983","unstructured":"Young LS (1983) Antimicrobial prophylaxis against infection in neutropenic patients. J Infect Dis 147: 611\u2013614","journal-title":"J Infect Dis"},{"key":"40_CR60","doi-asserted-by":"crossref","first-page":"144","DOI":"10.7326\/0003-4819-106-1-144","volume":"106","author":"LS Young","year":"1987","unstructured":"Young LS (1987) The new fluorinated quinolones for infection prevention in acute leukemia. Ann Int Med 106: 144\u2013146","journal-title":"Ann Int Med"}],"container-title":["Recent Results in Cancer Research","Supportive Care in Cancer Patients II"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-84138-5_40.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T15:34:49Z","timestamp":1620315289000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-84138-5_40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991]]},"ISBN":["9783642841408","9783642841385"],"references-count":60,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-84138-5_40","relation":{},"ISSN":["0080-0015"],"issn-type":[{"type":"print","value":"0080-0015"}],"subject":[],"published":{"date-parts":[[1991]]}}}